Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

32 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Recruiting

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652

Conditions
Mental Disorders, Metabolic Diseases, Nervous System Diseases, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Yale Medicine North Haven, Connecticut, United States
  • Parkinson's Disease & Movement Disorders Center of Boca Raton Boca Raton, Florida, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

NCT07589595

Conditions
Alzheimer Disease, Amyloid, Basal Ganglia Diseases, +17 more
Locations
  • TrialSphere Corp Chandler, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Profound Research LLC Carlsbad, California, United States
  • Irvine Clinical Research Irvine, California, United States
View all 71 locations
View Trial Details
Recruiting

Ambroxol to Slow Progression in Parkinson Disease

NCT05778617

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • University Hospitals Birmingham Birmingham, United Kingdom
  • Southmead Hospital Bristol Bristol, United Kingdom
  • Addenbrookes NHS Trust Cambridge, United Kingdom
  • Western General Hospital Edinburgh, United Kingdom
View all 15 locations
View Trial Details

Related conditions